Abstract
As a medical device manufacturer, one is often confronted with questions regarding the correct application of risk management for medical devices. For example, it is important to know from the outset which regulations or legal bases apply to risk management. For the implementation of the risk management process, it is important to know which phases it has to go through and which methods and tools are helpful in the implementation. And, of course, it is also important to know which documents have to be created and which prerequisites have to be fulfilled in order to be able to perform a risk assessment, for example.
To answer these questions, this chapter highlights the relevant regulations and laws for risk management in the development and manufacturing of medical devices. Furthermore, the risk management process in the life cycle of a medical device is presented, and the procedure for its implementation is outlined. In addition, the individual elements of the risk management process are described and discussed in detail. All documents that are considered as evidence of the establishment of a complete risk management process are presented, and their necessary content is shown. The most commonly used risk management methods, such as fault tree analysis, Ishikawa diagram, and failure mode and effects analysis, are described, and the strengths and weaknesses of these methods are discussed. Finally, the use of knowledge-based software systems for risk management is discussed, as these software systems are increasingly coming into focus to enable knowledge management in risk management.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AIMDD :
-
Active Implantable Medical Device Directive
- ALARP:
-
As low as reasonably practicable
- CEN/CENELEC:
-
European Committee for Standardization (CEN) and European Committee for Electrotechnical Standardization (CENELEC)
- EN:
-
European norm
- EU:
-
European Union
- FDA:
-
Food and Drug Administration
- FMEA:
-
Failure mode and effects analysis
- FMECA:
-
Failure modes, effects, and criticality analysis
- FTA:
-
Fault tree analysis
- GHTF:
-
Global Harmonization Task Force
- GMP:
-
Good manufacturing practice
- HACCP:
-
Hazard analysis and critical control points
- HAZOP:
-
Hazard and operability study
- ICH:
-
International Conference on Harmonisation
- IEC:
-
International Electrotechnical Commission
- ISO:
-
International Organization for Standardization
- IVDD:
-
In Vitro Diagnostic Medical Device Directive
- IVDR:
-
In Vitro Diagnostic Medical Device Regulation
- MDD:
-
Medical Devices Directive
- MDR:
-
Medical Device Regulation
- RA:
-
Risk assessment
- REXS:
-
Risk expert system
- RM:
-
Risk management
- RPN:
-
Risk priority number
References
CEN/CENELEC (2012) European Committee for Standardization and European Committee for Electrotechnical Standardization (CEN/CENELEC): EN ISO 14971:2012 medical devices – application of risk management to medical devices
CEN/CENELEC (2016) European Committee for Standardization and European Committee for Electrotechnical Standardization (CEN/CENELEC): EN ISO 13485:2016 medical devices – quality management systems – requirements for regulatory purposes
CEN/CENELEC (2019) European Committee for Standardization and European Committee for Electrotechnical Standardization (CEN/CENELEC): EN ISO 14971:2019 medical devices – application of risk management to medical devices
CEN/CENELEC (2020) European Committee for Standardization and European Committee for Electrotechnical Standardization (CEN/CENELEC): CEN ISO/TR 24971:2020 medical devices – guidance on the application of ISO 14971
European Parliament and of the Council: Council Directive 90/385/EEC relating to active implantable medical devices – AI-MDD, Official Journal L 189, P. 0017–0036 from 20.07.1990. Retrieved on September 01, 2022a., from EUR-Lex – 31990L0385 – EN – EUR-Lex (europa.eu)
European Parliament and of the Council: Council Directive 93/42/EEC concerning medical devices – MDD, Official Journal L 169, P. 0001–0043 from 12.07.1993. Retrieved on September 01, 2022b, from EUR-Lex – 31993L0042 – EN – EUR-Lex (europa.eu)
European Parliament and of the Council: Directive 98/79/EC on in vitro diagnostic medical devices – IVDD, Official Journal L 331, P. 0001–0037 from 07.12.1998. Retrieved on September 01, 2022c., from EUR-Lex – 31998L0079 – EN – EUR-Lex (europa.eu)
European Parliament and of the Council: Regulation (EU) 2017/745: Regulation on medical devices – MDR, Version from 05.04.2017. Retrieved on September 01, 2022 from EUR-Lex – 32017R0745 – EN – EUR-Lex (europa.eu)
European Parliament and of the Council: Regulation (EU) 2017/746: Regulation on in vitro diagnostic medical devices – IVDR, Version from 05.04.2017. Retrieved on September 01, 2022 from, EUR-Lex – 32017R0746 – EN – EUR-Lex (europa.eu)
Global Harmonization Task Force (GHTF): Implementation of risk management principles and activities within a Quality Management System (SG3/N15R8/2005) (2005) Retrieved on September 01, 2022, from http://www.imdrf.org/docs/ghtf/final/sg3/technical-docs/ghtf-sg3-n15r8-risk-management-principles-qms-050520.pdf
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH): ICH Harmonised guideline – quality risk management Q9 (R1) – final version adopted on 18 January (2023) Retrieved on February 14, 2023, from https://database.ich.org/sites/default/files/ICH_Q9%28R1%29_Guideline_Step4_2023_0126_0.pdf
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH): ICHQ9 briefing pack (2006) Retrieved on February 15, 2023 from https://ich.org/page/q9-briefing-pack
International Electrotechnical Commission (IEC): International Standard 61882, first edition: Hazard and operability studies (HAZOP studies) – application guide (2001)
International Electrotechnical Commission (IEC): International Standard 61025, second edition: Fault tree analysis (FTA) (2006)
International Electrotechnical Commission (IEC): International Standard IEC 60812:2018 Failure modes and effects analysis (FMEA and FMECA) (2018)
Johner C, Hölzer-Klüpfel M, Wittorf S (2011) Basiswissen Medizinische Software. dpunkt
Maier M (2021) Methoden und Instrumente des Qualitätsrisikomanagements. In: GMP-Berater (AL60), Kapitel 19.D.6; GMP Verlag Maas & Peithner
Preis R (2009) Methoden der Risikoanalyse in der Technik. TÜV Austria Akademie
Rempe P (2021) Anforderungen an Qualitätsrisikomanagement aus Behördensicht. In: GMP-Berater (AL59), Kapitel 19.A; GMP Verlag Maas & Peithner
U. S. Food and Drug Administration (FDA): National Advisory Committee on Microbiological Criteria for Foods; HACCP Principles & Application Guidelines (1997) Retrieved on February 02, 2023 from https://www.fda.gov/food/hazard-analysis-critical-control-point-haccp/haccp-principles-application-guidelines
U. S. Food and Drug Administration (FDA): Guidance for Industry: Juice Hazard Analysis Critical Control Point Hazards and Controls Guidance, First Edition (2004). Retrieved on September 01 2022 https://www.fda.gov/regulatory-information/search-fda-guidance-documents/guidance-industry-juice-hazard-analysis-critical-control-point-hazards-and-controls-guidance-first
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this entry
Cite this entry
Gübitz, B., Klinger, U. (2023). Risk Management for Medical Devices in Compliance with EN ISO 14971. In: Baumgartner, C., Harer , J., Schröttner, J. (eds) Medical Devices and In Vitro Diagnostics. Reference Series in Biomedical Engineering(). Springer, Cham. https://doi.org/10.1007/978-3-031-22091-3_6
Download citation
DOI: https://doi.org/10.1007/978-3-031-22091-3_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-22090-6
Online ISBN: 978-3-031-22091-3
eBook Packages: EngineeringReference Module Computer Science and Engineering